Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
While the East Coast grappled with the aftermath of downpours that closed roads and rendered the water supply undrinkable in places, the West and other parts of the country contended with sizzling temperatures and unsafe air quality attributed to Canadian wildfires.
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
A group of bipartisan senators is calling for the release of public records on UFOs.
Results of late-stage clinical trials are showing promising results for a new Alzheimer's Drug from Eli Lilly.
Over a dozen states are under air quality alerts as smoke from the Canadian wildfires continues to make its way across the country.
Millions of Americans continue to be under a heat advisory as extreme temperatures are still affecting the southern U.S.
Florida's latest invasive species comes a-hoppin' down the street: lionhead rabbits.
Be Well: Understanding Mosquito and Tick-Borne Illnesses Ahead of Your Summer Ventures
Be Well: How to Improve Your Core Strength in Four Minutes
